Evidence map›Paper›PMID 40022712›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

Expression Analysis of Oxidative Stress Markers 8-hydroxydeoxyguanosine and Protein Carbonyl in Breast Cancer and Their associations with Certain Immunological and Tumor Markers.

Saddek Yahia, Zineb Tahari, Asmahane Medjdoub, Nadia Bessaih, Moussa Messatfa, Mourad Raiah, Houria Ouldcadi, Amel Soulef Saadi Ouslim, Sonia Seddiki, Tewfik Sahraoui

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Saddek YahiaBiology of Development and Differentiation Laboratory, Ahmed Ben Bella Oran 1 University, Oran, Algeria.ORCID 0000-0001-9768-1778
Zineb TahariBiology of Development and Differentiation Laboratory, Ahmed Ben Bella Oran 1 University, Oran, Algeria.
Asmahane MedjdoubBiology of Development and Differentiation Laboratory, Ahmed Ben Bella Oran 1 University, Oran, Algeria.
Nadia BessaihDepartment of Medical Oncology, University Hospital Establishment of Oran, Faculty of Medicine, Ahmed Ben Bella Oran 1 University, Oran, Algeria.
Moussa MessatfaFaculty of Medicine, Abdelhamid Ben Badis University Mostaganem, Mostaganem, Algeria.
Mourad RaiahDepartment of Epidemiology and Preventive Medicine, University Hospital of Oran, Faculty of Medicine, Ahmed Ben Bella Oran 1 University, Oran, Algeria.
Houria OuldcadiBiology of Development and Differentiation Laboratory, Ahmed Ben Bella Oran 1 University, Oran, Algeria.
Amel Soulef Saadi OuslimBiology of Development and Differentiation Laboratory, Ahmed Ben Bella Oran 1 University, Oran, Algeria.
Sonia SeddikiBiology of Development and Differentiation Laboratory, Ahmed Ben Bella Oran 1 University, Oran, Algeria.
Tewfik SahraouiBiology of Development and Differentiation Laboratory, Ahmed Ben Bella Oran 1 University, Oran, Algeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveBreast cancer (BC) is a heterogeneous disease, recognized as a major public health problem worldwide, with several risk factors including oxidative stress, an imbalance between the production of reactive oxygen species (ROS) and antioxidant capacity. The aim of this study is to evaluate oxidative stress markers 8-Hydroxydeoxyguanosine (8-OHdG) and protein carbonyl and their associations with pathological and immunohistochemical parameters as well as the immune system in particular Interleukin-6 (IL-6) in BC patients from western Algeria.

methodsWe analyzed serum concentrations of 8-OHdG and IL-6 by Eliza technique and protein carbonyl by derivatization of protein carbonyl groups with 2,4-dinitrophenylhydrazine (DNPH), then associated them with immunohistochemical and pathological parameters, as well as in the different molecular and histological groups of BC.

resultsOur results show that there was no significant difference in serum concentrations of 8-OHdG and protein carbonyl, between controls and patients, and a negative correlation between these markers and lymph node count as well as with proliferation protein Ki-67. We also found a significant association between the DNA oxidation marker 8-OHdG and Human epidermal growth factor receptor 2 (HER2) expression. No association was found between oxidative stress markers and IL-6. Furthermore, no significant differences in serum levels of 8-OHdG and protein carbonyl were found in the different histological types and molecular classes of BC.

conclusionOur results show that our patients do not have oxidative stress and that physiological ROS concentrations represent a good prognostic indicator, particularly in cancer cell proliferation through their negative correlation with Ki-67, and also metastatic lymph node count. Moreover, HER2 probably has the capacity to modify the state of oxidative stress, notably DNA oxidation. Finally, different molecular and histological types of BC have the same oxidative stress level and antioxidant capacity.

Indexed as

Biomarkers, TumorBreast NeoplasmsCarcinoma, Ductal, BreastDeoxyguanosineOxidative StressProtein Carbonylation8-Hydroxy-2'-DeoxyguanosineAdultAgedCase-Control StudiesErb-b2 Receptor Tyrosine KinasesFemaleFollow-Up StudiesHumansInterleukin-6Middle Aged8-Hydroxy-2'-DeoxyguanosineBiomarkers, TumorDeoxyguanosineErb-b2 Receptor Tyrosine KinasesInterleukin-6Reactive Oxygen Specieshuman epidermal growth factor receptor 2Interleukin-6Ki-67oxidative stressreactive oxygen species

Identifiers

PMID40022712
PMCPMC12118038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.